Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1291, 2001-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
TNF- inhibitors: `new era' of biological therapies for RA?
Inpharma, Vol. 1, Iss. 1267, 2000-01 ,pp. :
Access to resources
Recommend
New therapies for mature T-cell leukaemia?
Inpharma, Vol. 1, Iss. 1315, 2001-01 ,pp. :
New therapies for acute coronary syndrome: which will be of value?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 262, 2000-01 ,pp. :
Which therapies warranted for postmenopausal osteoporosis?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 370, 2002-01 ,pp. :
Will GLP-1-based therapies substitute sulfonylureas?
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :